Larotrectinib Capsules and ME/NaPhos/MB/Hyo1
Determining the interaction of Larotrectinib Capsules and ME/NaPhos/MB/Hyo1 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Measles and rubella virus vaccine live Intramuscular, Injection
- Larotrectinib Capsules-Measles virus vaccine, live Subcutaneous
- Larotrectinib Capsules-Measles, mumps, and rubella (MMR) vaccine
- Larotrectinib Capsules-Measles, Mumps, and Rubella Vaccine
- Larotrectinib Capsules-Measles, Mumps, and Rubella Virus Vaccine
- Larotrectinib Capsules-Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular
- ME/NaPhos/MB/Hyo1-Larotrectinib Oral Solution
- ME/NaPhos/MB/Hyo1-Larotrectinib Sulfate
- ME/NaPhos/MB/Hyo1-Lartruvo
- ME/NaPhos/MB/Hyo1-Larynex
- ME/NaPhos/MB/Hyo1-Laryng-O-Jet
- ME/NaPhos/MB/Hyo1-Laryngesic